Please select the option that best describes you:

How would you manage a medically inoperable patient with an invasive squamous cell carcinoma of the oropharynx and extensive adjacent leukoplakia harboring pathologically-proven in situ disease?  

 What is your radiotherapy approach? How large is your treatment field, and for the leukoplakia/in situ disease, what is your dose?



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Generations Radiotherapy and Oncology PC
Very helpful. Thank you!
Radiation Oncologist at Ohio State University James Cancer Center
@William M. Mendenhall, can you comment in general...
Radiation Oncologist at University of Florida
Hyperfractionation is likely the best schedule for...
Radiation Oncologist at Ohio State University James Cancer Center
@William M. Mendenhall, many thanks and respectful...
Radiation Oncologist at University of Florida
We started using hyperfractionation in 1978 having...
Radiation Oncologist at Jacob E Locke MD PA
SIB 66/60/54 to keep the lowest dose level at 1.8/...
Sign in or Register to read more